Drug Delivery Consortium

SHORT COURSE - Pharmaceutical Development: From Drug Lead to Drug Product 

Two-week short-course on pharmaceutical development this summer May 27 – June 9, 2014 for graduate students and postdocs from Georgia Tech and other Atlanta-area universities (Emory, Mercer, Georgia State).

This course was first offered in 2012, read about it here. 

Instructors: Mark Prausnitz and Andy Bommarius with co-instructors and guest lecturers from Atlanta-area companies and universities

     Prerequisites:                         Graduate standing with intent to pursue a PhD focused on pharmaceutical research.

     Course credit:                         3 units

     Course meeting time:              9 AM – 5 PM on May 27, 28, 29, 30; June 2, 3, 4, 5, 6, 9

     Course meeting location:         Georgia Tech campus

     Course number:                       CHBE 8803 (Georgia Tech); course numbers are being set up at Mercer, Emory, GSU


Course Description                         

Doctoral students from biochemistry, bioengineering, pharmacology, pharmacy, and other fields will work as part of interdisciplinary teams to simulate the drug development process starting with a druggable lead and ending with a report to “upper management” giving the scientific and business plan for development into an approved drug product. The course will follow an intensive, all-day, short-course format for ten consecutive weekdays with faculty lectures and student project teamwork. The goal of the course is to teach students the multifaceted process needed to bring a drug from concept to market in the context of open-ended, student-driven, collaborative projects addressing real-world problems in pharmaceutical development.  This course was first offered in 2012 with great success (see press release at http://www.gatech.edu/newsroom/release.html?nid=135791).


Course syllabus




May 27

Introduction to class and pharmaceutical development

Project teamwork and communication


May 28

From drug lead to drug molecule


May 29

Target indication, patient population


May 30

Drug manufacturing scale up and GMP


June 2

Formulation, route of administration, drug delivery systems


June 3

Design of IND-enabling studies: CMC, PK/PD and toxicology


June 4

Clinical trial design


June 5

Pharmaceutical marketing


June 6

Oral presentations and reports / business plan


June 9

Final presentations





Please contact Mark Prausnitz for a registration permit or for more information.